Compare HIMS & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HIMS | ENSG |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.7B |
| IPO Year | 2019 | 2007 |
| Metric | HIMS | ENSG |
|---|---|---|
| Price | $32.78 | $172.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 5 |
| Target Price | $30.46 | ★ $202.60 |
| AVG Volume (30 Days) | ★ 14.8M | 742.2K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.14% |
| EPS Growth | N/A | ★ 14.06 |
| EPS | N/A | ★ 1.67 |
| Revenue | $2,347,637,000.00 | ★ $5,057,841,000.00 |
| Revenue This Year | $19.82 | $17.07 |
| Revenue Next Year | $19.23 | $9.49 |
| P/E Ratio | ★ N/A | $103.02 |
| Revenue Growth | ★ 59.00 | 18.72 |
| 52 Week Low | $13.74 | $134.80 |
| 52 Week High | $70.43 | $218.00 |
| Indicator | HIMS | ENSG |
|---|---|---|
| Relative Strength Index (RSI) | 48.73 | 58.95 |
| Support Level | $29.39 | $169.98 |
| Resistance Level | $36.22 | $182.46 |
| Average True Range (ATR) | 2.35 | 4.19 |
| MACD | -0.62 | 1.05 |
| Stochastic Oscillator | 15.90 | 80.75 |
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.